BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 17958775)

  • 1. Continued treatment of chronic hepatitis C despite development of interferon-associated retinopathy.
    Cedar MA; Zancosky KL; Oliva LA; Molloy PJ; Weissgold DJ; Krawitt EL
    Am J Gastroenterol; 2007 Nov; 102(11):2612-3. PubMed ID: 17958775
    [No Abstract]   [Full Text] [Related]  

  • 2. [Interferon-related retinopathy in a man with chronic hepatitis C].
    Viennet A; Glatre F; Bacin F
    J Fr Ophtalmol; 2009 Sep; 32(7):505-10. PubMed ID: 19592135
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Retinopathy during interferon treatment in combination with ribavirin for chronic hepatitis C].
    Nakamura T; Takahashi H; Koike N; Mitsutaka M; Soda M; Kimu M
    Nippon Ganka Gakkai Zasshi; 2005 Nov; 109(11):748-52. PubMed ID: 16363669
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Should we investigate retinopathy in chronic hepatitis C patients receiving treatment with interferon?
    Aoufi Rabih S; Alfaya Muñoz LB; Fidalgo Broncano A; Villanueva Hernández R; González Carro P; Pérez Roldán F
    Eur J Gastroenterol Hepatol; 2014 Feb; 26(2):242-3. PubMed ID: 24366452
    [No Abstract]   [Full Text] [Related]  

  • 5. [Pegylated-interferon-associated retinopathy].
    Pérez-Alvarez MJ; Montes-Ramírez ML; Machín-Lázaro JM; Rodríguez-Zapata M
    Enferm Infecc Microbiol Clin; 2007 Mar; 25(3):217. PubMed ID: 17335705
    [No Abstract]   [Full Text] [Related]  

  • 6. Pegylated interferon-associated retinopathy in chronic hepatitis C patients.
    Ogata H; Suzuki H; Shimizu K; Ishikawa H; Izumi N; Kurosaki M
    Jpn J Ophthalmol; 2006; 50(3):293-5. PubMed ID: 16767392
    [No Abstract]   [Full Text] [Related]  

  • 7. Hepatitis C: a review of diagnosis, management, and ocular complications from treatment.
    Tsolakos A; Zalatimo N
    Optometry; 2003 Aug; 74(8):517-23. PubMed ID: 12926825
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Retinopathy is not the only ocular symptom: myasthenia gravis in association with interferon therapy.
    Oishi A; Miyamoto K; Kashii S; Yoshimura N
    Br J Ophthalmol; 2005 Nov; 89(11):1542-3. PubMed ID: 16234478
    [No Abstract]   [Full Text] [Related]  

  • 9. Retinal circulatory changes associated with interferon-induced retinopathy in patients with hepatitis C.
    Nagaoka T; Sato E; Takahashi A; Yokohama S; Yoshida A
    Invest Ophthalmol Vis Sci; 2007 Jan; 48(1):368-75. PubMed ID: 17197556
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Retinopathy in chronic hepatitis C patients during interferon treatment: a case report.
    Rossi C; Scotton PG; Farina F; Vaglia A
    Infez Med; 2010 Dec; 18(4):267-9. PubMed ID: 21196822
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Posterior segment complications in patients with hepatitis C treated with interferon and ribavirin.
    Schulman JA; Liang C; Kooragayala LM; King J
    Ophthalmology; 2003 Feb; 110(2):437-42. PubMed ID: 12578794
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blurred vision: cause? Retinopathy secondary to interferon treatment.
    Bowen DW; Vyas S
    Gut; 2006 Feb; 55(2):211, 251. PubMed ID: 16407386
    [No Abstract]   [Full Text] [Related]  

  • 13. Incidence and risk factors of retinopathy in Egyptian patients with chronic hepatitis C virus treated with pegylated interferon plus ribavirin.
    Fouad YM; Khalaf H; Ibraheem H; Rady H; Helmy AK
    Int J Infect Dis; 2012 Jan; 16(1):e67-71. PubMed ID: 22115957
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interferon-associated retinopathy in a uniform regimen of natural interferon-alpha therapy for chronic hepatitis C.
    Saito H; Ebinuma H; Nagata H; Inagaki Y; Saito Y; Wakabayashi K; Takagi T; Nakamura M; Katsura H; Oguchi Y; Ishii H
    Liver; 2001 Jun; 21(3):192-7. PubMed ID: 11422782
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low incidence of retinopathy during peginterferon alpha-2b and lamivudine therapy for chronic hepatitis B.
    Buster EH; Ter Borg MJ; Vingerling JR; Janssen HL
    J Hepatol; 2006 Jul; 45(1):160-1; author reply 161-2. PubMed ID: 16723166
    [No Abstract]   [Full Text] [Related]  

  • 16. Vitiligo associated with alpha-interferon in a patient with chronic active hepatitis C.
    Nouri K; Busso M; Machler BC
    Cutis; 1997 Dec; 60(6):289-90. PubMed ID: 9426968
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interferon alfa, peginterferon alfa and retinopathy.
    Prescrire Int; 2006 Apr; 15(82):61-2. PubMed ID: 16607695
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angioedema after interferon therapy for chronic hepatitis C.
    Ohmoto K; Yamamoto S
    Am J Gastroenterol; 2001 Apr; 96(4):1311-2. PubMed ID: 11316204
    [No Abstract]   [Full Text] [Related]  

  • 19. [Pulmonary sarcoidosis--a rare complication of interferon treatment for chronic hepatitis C].
    Pellová A; Pella J; Schréter I; Somos A; Kristian P; Boom A
    Klin Mikrobiol Infekc Lek; 2006 Oct; 12(5):200-2. PubMed ID: 17080355
    [No Abstract]   [Full Text] [Related]  

  • 20. [Acute pericardite which has occurred during the treatment of chronic hepatitis C by the interferon alpha2A].
    Hamdani I; Kochlef A; Belhadj N; Kharrat J; Ghorbel A
    Tunis Med; 2008 Apr; 86(4):404-5. PubMed ID: 19476158
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.